BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 28582327)

  • 1. A comprehensive review of Asherman's syndrome: causes, symptoms and treatment options.
    Salazar CA; Isaacson K; Morris S
    Curr Opin Obstet Gynecol; 2017 Aug; 29(4):249-256. PubMed ID: 28582327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hysteroscopic Management of Asherman's Syndrome.
    Khan Z; Goldberg JM
    J Minim Invasive Gynecol; 2018 Feb; 25(2):218-228. PubMed ID: 29024798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoring Fertility of Patients with Severe Asherman's Syndrome in the Office Setting: A Step-by-Step Recipe for Success.
    Di Spiezio-Sardo A; De Angelis MC; Dimitrios K; Manzi A; Zizolfi B; Carugno J; Isaacson K
    J Minim Invasive Gynecol; 2023 May; 30(5):355-356. PubMed ID: 36764649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A matched cohort study comparing the outcome of intrauterine adhesiolysis for Asherman's syndrome after uterine artery embolization or surgical trauma.
    Song D; Liu Y; Xiao Y; Li TC; Zhou F; Xia E
    J Minim Invasive Gynecol; 2014; 21(6):1022-8. PubMed ID: 24842805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intrauterine adhesions--Asherman's syndrome].
    Heinonen PK
    Duodecim; 2010; 126(21):2486-91. PubMed ID: 21171473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hysteroscopic treatment of Asherman's syndrome.
    Magos A
    Reprod Biomed Online; 2002; 4 Suppl 3():46-51. PubMed ID: 12470565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of de novo adhesion formation in patients with Asherman's syndrome.
    BarboraBoudová Barbora; Lisá Zdeňka; Richtárová Adéla; Kužel D; MichalMára Michal
    Ceska Gynekol; 2021; 86(4):273-278. PubMed ID: 34493053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial Regeneration in Asherman's Syndrome: Clinical and Translational evidence of Stem Cell Therapies.
    Hou X; Liu Y; Streuli I; Dällenbach P; Dubuisson J; Ansaldi Y; Pluchino N
    Curr Stem Cell Res Ther; 2019; 14(6):454-459. PubMed ID: 30760192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting reproductive outcome of hysteroscopic adhesiolysis for Asherman's syndrome.
    Yu D; Li TC; Xia E; Huang X; Liu Y; Peng X
    Fertil Steril; 2008 Mar; 89(3):715-22. PubMed ID: 17681324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-uterine adhesions and fertility outcome: how to optimize success?
    Kodaman PH; Arici A
    Curr Opin Obstet Gynecol; 2007 Jun; 19(3):207-14. PubMed ID: 17495635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of early intervention of second-look office hysteroscopy in the prevention of adhesion reformation for moderate-severe Asherman's syndrome].
    Li C; Wei ML; Lin XN; Huang QX; Huang D; Zhang SY
    Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(45):3617-9. PubMed ID: 24534315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study.
    Santamaria X; Cabanillas S; Cervelló I; Arbona C; Raga F; Ferro J; Palmero J; Remohí J; Pellicer A; Simón C
    Hum Reprod; 2016 May; 31(5):1087-96. PubMed ID: 27005892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of 3D ultrasound in the management of suspected Asherman's syndrome.
    Knopman J; Copperman AB
    J Reprod Med; 2007 Nov; 52(11):1016-22. PubMed ID: 18161399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of false passage created during hysteroscopic adhesiolysis for Asherman's syndrome.
    Song D; Xia E; Xiao Y; Li TC; Huang X; Liu Y
    J Obstet Gynaecol; 2016; 36(1):87-92. PubMed ID: 26207696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine adhesions.
    Berman JM
    Semin Reprod Med; 2008 Jul; 26(4):349-55. PubMed ID: 18756412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hysteroscopic treatment of severe Asherman's syndrome and subsequent fertility.
    Capella-Allouc S; Morsad F; Rongières-Bertrand C; Taylor S; Fernandez H
    Hum Reprod; 1999 May; 14(5):1230-3. PubMed ID: 10325268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asherman's syndrome.
    March CM
    Semin Reprod Med; 2011 Mar; 29(2):83-94. PubMed ID: 21437822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification systems of Asherman's syndrome. An old problem with new directions.
    Manchanda R; Rathore A; Carugno J; Della Corte L; Tesarik J; Török P; Vilos GA; Vitale SG
    Minim Invasive Ther Allied Technol; 2021 Oct; 30(5):304-310. PubMed ID: 33660561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology, treatment, and reproductive prognosis of women with moderate-to-severe intrauterine adhesions.
    Xiao S; Wan Y; Xue M; Zeng X; Xiao F; Xu D; Yang X; Zhang P; Sheng W; Xu J; Zhou S
    Int J Gynaecol Obstet; 2014 May; 125(2):121-4. PubMed ID: 24598346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Future reproductive ability in post-treatment Asherman's syndrome patients].
    Cruz Orozco OP; Castellanos Barroso G; Gaviño Gaviño F; De la Jara Díaz J; García Vargas J; Roque Sánchez AM
    Ginecol Obstet Mex; 2012 Jun; 80(6):389-93. PubMed ID: 22826966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.